Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the Superficial Femoral Artery (SFA).

Trial Profile

Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the Superficial Femoral Artery (SFA).

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral arterial disorders
  • Focus Therapeutic Use
  • Acronyms DESPERADO
  • Most Recent Events

    • 05 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
    • 12 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2017.
    • 14 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top